Logo

HTG Molecular

In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More

News items for the week of Jan. 3, 2023.

HTG Molecular Diagnostics to Raise $10M in Public Offering

The firm plans to use the net proceeds from the offering for general corporate purposes including research and development, clinical trials, capital expenditures, and working capital.

HTG Molecular Diagnostics to Implement Reverse Stock Split

Last month, the company reported a 48 percent year-over-year drop in third quarter revenues as it repositions itself as a developer of drug discovery technologies.

Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen

The genomic and diagnostics firms posted quarterly financial results late this week.

HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy

Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.

Aug 26, 2022

People in the News at Gencove, IsoPlexis, HTG Molecular, More

Aug 11, 2022

Earnings Roundup: Cytek Biosciences, ProPhase Labs, Applied DNA Sciences, Co-Diagnostics, More

Jun 10, 2022

In Brief This Week: T2 Biosystems, HTG, Thermo Fisher, Dante Genomics, OriCiro Genomics, More

May 13, 2022

In Brief This Week: Co-Diagnostics, Oxford Nanopore, Prenetics, Dante Labs, Seegene, More

Mar 29, 2022

HTG Molecular Diagnostics 2021 Revenues Grow 5 Percent

Jan 7, 2022

In Brief This Week: Cue Health, Qiagen, Co-Diagnostics, Vela Diagnostics, Thermo Fisher, HTG, More

Jan 6, 2022

HTG Molecular Expects 5 Percent Rise in 2021 Revenues

Nov 12, 2021

In Brief This Week: Caris Life Sciences, Psomagen, Tempus, CareDx, HTG Molecular, Epigenomics, More

Aug 12, 2021

HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease

Aug 6, 2021

New Products Posted to GenomeWeb: HTG Molecular, Myriad Genetics, Eclipse Bioinnovations, More

May 13, 2021

HTG Molecular Diagnostics Q1 Revenues Drop 36 Percent

Apr 5, 2021

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

Mar 25, 2021

HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent

Jan 5, 2021

HTG Molecular Preliminary 2020 Revenues Drop 56 Percent

Nov 23, 2020

HTG Molecular Completes 1-For-15 Reverse Stock Split

Nov 11, 2020

HTG to Expand Disease Reach With New Whole-Transcriptome Profiling Product Mid-2021
Premium

Nov 10, 2020

HTG Molecular Diagnostics Q3 Revenues Drop 67 Percent

Aug 13, 2020

BioSpyder Seeks Noninfringement Judgment in HTG Molecular Patent Dispute

Aug 12, 2020

HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

Aug 10, 2020

HTG Molecular Diagnostics, Qiagen Ink CDx Commercialization, Distribution Agreement

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.